Oncology Central

Breakthrough targeted therapeutic approaches to squamous cell carcinoma of the head and neck


Head and neck squamous cell carcinoma (HNSCC) represents the vast majority (i.e., more than 90%) of head and neck tumors. Notably, HNSCC represents the sixth most common cancer worldwide and currently, for this tumor, an incidence of over 600,000 people per year is reported [1,2].

To view restricted content, please:

Leave A Comment